The impact of obstructive sleep apnea on homocysteine and carotid remodeling in metabolic syndrome

Respiratory Physiology and Neurobiology

Volumn 180, Issue 2-3, 2012, Pages 298-304

  Monneret, D ^a,b   Tamisier, R ^a,b   Ducros, V ^b   Garrel, C ^b   Levy, P ^a,b   Baguet, J P ^b   Faure, P ^a,b   Pepin J L ^a,b  

^a University Grenoble Alpes   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Carotid intima media thickness; Homocysteine; Metabolic syndrome; Obstructive sleep apnea; Oxidative stress; Plasma thiols; Urinary 15 F 2t isoprostane

Indexed keywords

15 F2T ISOPROSTANE; HOMOCYSTEINE; ISOPROSTANE; THIOL; UNCLASSIFIED DRUG;

ADULT; APNEA HYPOPNEA INDEX; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OXIDATIVE STRESS; POLYSOMNOGRAPHY; PRIORITY JOURNAL; SLEEP APNEA SYNDROME; URINALYSIS;

ANTIOXIDANTS; AROUSAL; ATHEROSCLEROSIS; BLOOD PRESSURE; CAROTID ARTERIES; CAROTID INTIMA-MEDIA THICKNESS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENDOTHELIUM, VASCULAR; FEMALE; HOMOCYSTEINE; HUMANS; ISOPROSTANES; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OXIDATION-REDUCTION; OXIDATIVE STRESS; POLYSOMNOGRAPHY; SLEEP APNEA, OBSTRUCTIVE; SULFHYDRYL COMPOUNDS; TANDEM MASS SPECTROMETRY;

EID: 84856416440     PISSN: 15699048     EISSN: 18781519     Source Type: Journal    
DOI: 10.1016/j.resp.2011.12.009     Document Type: Article

References (32)

1. Anon. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999, 22:667-689.
2. Anon. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J. Hypertens. 2003, 21:1011-1053.
3. Anon. Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. Am. J. Clin. Nutr. 2005, 82:806-812.
4. Alberti K.G., Zimmet P., Shaw J. The metabolic syndrome - a new worldwide definition. Lancet 2005, 366:1059-1062.
5. Ashfaq S., Abramson J.L., Jones D.P., Rhodes S.D., Weintraub W.S., Hooper W.C., Vaccarino V., Harrison D.G., Quyyumi A.A. The relationship between plasma levels of oxidized and reduced thiols and early atherosclerosis in healthy adults. J. Am. Coll. Cardiol. 2006, 47:1005-1011.
6. Baguet J.P., Mallion J.M., Moreau-Gaudry A., Noirclerc M., Peoc'h M., Siche J.P. Relationships between cardiovascular remodelling and the pulse pressure in never treated hypertension. J. Hum. Hypertens. 2000, 14:23-30.
7. Bixler E.O., Vgontzas A.N., Lin H.M., Calhoun S.L., Vela-Bueno A., Kales A. Excessive daytime sleepiness in a general population sample: the role of sleep apnea, age, obesity, diabetes, and depression. J. Clin. Endocrinol. Metab. 2005, 90:4510-4515.
8. Bonetti P.O., Pumper G.M., Higano S.T., Holmes D.R., Kuvin J.T., Lerman A. Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J. Am. Coll. Cardiol. 2004, 44:2137-2141.
9. Coughlin S.R., Mawdsley L., Mugarza J.A., Calverley P.M., Wilding J.P. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur. Heart J. 2004, 25:735-741.
10. Demuth K., Drunat S., Girerd X., Moatti N., Paul J.L., Safar M., Boutouyrie P. Homocysteine is the only plasma thiol associated with carotid artery remodeling. Atherosclerosis 2002, 165:167-174.
11. Drager L.F., Bortolotto L.A., Maki-Nunes C., Trombetta I.C., Alves M.J., Fraga R.F., Negrao C.E., Krieger E.M., Lorenzi-Filho G. The incremental role of obstructive sleep apnoea on markers of atherosclerosis in patients with metabolic syndrome. Atherosclerosis 2010, 208:490-495.
12. Drager L.F., Lopes H.F., Maki-Nunes C., Trombetta I.C., Toschi-Dias E., Alves M.J., Fraga R.F., Jun J.C., Negrao C.E., Krieger E.M., Polotsky V.Y., Lorenzi-Filho G. The impact of obstructive sleep apnea on metabolic and inflammatory markers in consecutive patients with metabolic syndrome. PLoS One 2010, 5:e12065.
13. Ducros V., Belva-Besnet H., Casetta B., Favier A. A robust liquid chromatography tandem mass spectrometry method for total plasma homocysteine determination in clinical practice. Clin. Chem. Lab. Med. 2006, 44:987-990.
14. El-Khairy L., Ueland P.M., Refsum H., Graham I.M., Vollset S.E. Plasma total cysteine as a risk factor for vascular disease: the European Concerted Action Project. Circulation 2001, 103:2544-2549.
15. Faure P., Tamisier R., Baguet J.P., Favier A., Halimi S., Levy P., Pepin J.L. Impairment of serum albumin antioxidant properties in obstructive sleep apnoea syndrome. Eur. Respir. J. 2008, 31:1046-1053.
16. Faure P., Wiernsperger N., Polge C., Favier A., Halimi S. Impairment of the antioxidant properties of serum albumin in patients with diabetes: protective effects of metformin. Clin. Sci. (Lond.) 2008, 114:251-256.
17. Kokturk O., Ciftci T.U., Mollarecep E., Ciftci B. Serum homocysteine levels and cardiovascular morbidity in obstructive sleep apnea syndrome. Respir. Med. 2006, 100:536-541.
18. Lavie L., Perelman A., Lavie P. Plasma homocysteine levels in obstructive sleep apnea: association with cardiovascular morbidity. Chest 2001, 120:900-908.
19. Lonn E., Yusuf S., Arnold M.J., Sheridan P., Pogue J., Micks M., McQueen M.J., Probstfield J., Fodor G., Held C., Genest J. Homocysteine lowering with folic acid and B vitamins in vascular disease. New Engl. J. Med. 2006, 354:1567-1577.
20. Marin J.M., Carrizo S.J., Vicente E., Agusti A.G. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005, 365:1046-1053.
21. Monneret D., Pepin J.L., Godin-Ribuot D., Ducros V., Baguet J.P., Levy P., Faure P. Association of urinary 15-F(2t)-isoprostane level with oxygen desaturation and carotid intima-media thickness in nonobese sleep apnea patients. Free Radic. Biol. Med. 2009.
22. Morrow J.D., Hill K.E., Burk R.F., Nammour T.M., Badr K.F., Roberts L.J. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:9383-9387.
23. Pepin J.L., Delavie N., Pin I., Deschaux C., Argod J., Bost M., Levy P. Pulse transit time improves detection of sleep respiratory events and microarousals in children. Chest 2005, 127:722-730.
24. Pfanzagl B., Tribl F., Koller E., Moslinger T. Homocysteine strongly enhances metal-catalyzed LDL oxidation in the presence of cystine and cysteine. Atherosclerosis 2003, 168:39-48.
25. Pratico D., Iuliano L., Mauriello A., Spagnoli L., Lawson J.A., Rokach J., Maclouf J., Violi F., FitzGerald G.A. Localization of distinct F2-isoprostanes in human atherosclerotic lesions. J. Clin. Invest. 1997, 100:2028-2034.
26. Sabanayagam C., Shankar A. Sleep duration and cardiovascular disease: results from the National Health Interview Survey. Sleep 2010, 33:1037-1042.
27. Selhub J., Jacques P.F., Bostom A.G., D'Agostino R.B., Wilson P.W., Belanger A.J., O'Leary D.H., Wolf P.A., Schaefer E.J., Rosenberg I.H. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. New Engl. J. Med. 1995, 332:286-291.
28. Suzuki Y.J., Jain V., Park A.M., Day R.M. Oxidative stress and oxidant signaling in obstructive sleep apnea and associated cardiovascular diseases. Free Radic. Biol. Med. 2006, 40:1683-1692.
29. Svatikova A., Wolk R., Magera M.J., Shamsuzzaman A.S., Phillips B.G., Somers V.K. Plasma homocysteine in obstructive sleep apnoea. Eur. Heart J. 2004, 25:1325-1329.
30. Wald D.S., Law M., Morris J.K. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 2002, 325:1202.
31. Wiklund O., Fager G., Andersson A., Lundstam U., Masson P., Hultberg B. N-acetylcysteine treatment lowers plasma homocysteine but not serum lipoprotein(a) levels. Atherosclerosis 1996, 119:99-106.
32. Zinellu A., Lepedda A., Sotgia S., Zinellu E., Scanu B., Turrini F., Spirito R., Deiana L., Formato M., Carru C. Evaluation of low molecular mass thiols content in carotid atherosclerotic plaques. Clin. Biochem. 2009, 42:796-801.